Key result
Bisoprolol 2.5 mg normalizes blood pressure in ~89% of patients at 6 weeks.
Why the study?
The effects of anti-hypertensive drugs on haemodynamics, especially in Chinese populations, and the potential of non-invasive monitoring for these changes are poorly understood.
Does bisoprolol 2.5 mg alter haemodynamics (blood pressure, CO, SV, HR, SVR, inotropy) in Chinese patients with uncontrolled hypertension?
Observational (n=12)
Open-label
No
Does bisoprolol 2.5 mg alter haemodynamics (blood pressure, CO, SV, HR, SVR, inotropy) in Chinese patients with uncontrolled hypertension?
Long-term bisoprolol therapy effectively reduces blood pressure by reducing systemic vascular resistance in Chinese patients with uncontrolled hypertension.
Answers are grounded in this paper and cite their sources.
May support low-dose bisoprolol in select Chinese hypertension cases; hypothesis-generating and requires larger trials before adoption.
BACKGROUND: Anti-hypertensive drugs are widely used to control blood pressure, yet their effects on haemodynamics, especially in Chinese populations, and the potential for non-invasive methods to monitor these changes, are poorly understood. This study aimed to determine the early and late effects of bisoprolol treatment on blood pressure, cardiac output (CO), stroke volume (SV), heart rate (HR), systematic vascular resistance (SVR), and inotropy measured in Chinese patients with hypertension. METHODS: Twelve Chinese subjects (median age: 55 years, interquartile range: 52-58 years; 33% male) with uncontrolled hypertension were recruited at the Prince of Wales Hospital in Hong Kong and haemodynamic measurements were assessed using a non-invasive Ultrasonic Cardiac Output Monitor (USCOM). Seven hourly measurements were taken before and after bisoprolol 2.5 mg on day 1 (T0 to T6), and in nine patients this was repeated six weeks later (TF0 to TF6). Any BP change of 5 mmHg was considered clinically significant and P<0.05 was considered statistically significant. RESULTS: 104 [101-109] mmHg, P=0.038} reduced significantly 6 hours after bisoprolol treatment. Except for HR, all other measured haemodynamics returned to baseline at T6. On week 6 (N=9), SVR was generally reduced, but major parallel swings in CO and SVR were still evident. All patients showed a trend to lower blood pressure, SVR, and inotropy (P<0.05), but HR, SV, and CO returned to baseline values after 6 weeks treatment (P>0.05). CONCLUSIONS: The acute haemodynamic changes between 6 hours of the first dose and the dose after 6 weeks of bisoprolol treatment are similar. Long-term therapy can effectively reduce blood pressure by reducing SVR.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2021) conducted an observational in Uncontrolled hypertension (n=12). Bisoprolol vs. Baseline (pre-treatment after 2-week placebo run-in) was evaluated on Number of patients reaching target blood pressure of <140/90 mmHg after 6 weeks of treatment. Bisoprolol 2.5 mg daily normalized blood pressure (<140/90 mmHg) in 8 of 9 patients (88.9%) and reduced median sBP by 15 mmHg (P=0.008) and SVR by 5.6% (P=0.038) at 6 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: